Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Opal

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Current Infectious Disease Reports|August 2, 2012
Immune aspects of sepsis and hope for new therapeuticsSteven P Larosa, Steven M Opal
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Novel approaches to the treatment of systemic anthraxAndrew W Artenstein, Steven M Opal
Current Infectious Disease Reports|May 6, 2015
Sepsis in the severely immunocompromised patientAndre C Kalil, Steven M Opal
Critical Care Clinics|July 5, 2005
Tissue factor pathway inhibitor and antithrombin trial resultsSteven P LaRosa, Steven M Opal
Critical Care Medicine|November 27, 2013
The authors replySteven M Opal, R Phillip Dellinger
Virulence|November 9, 2013
The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shockAurora Pop-Vicas, Steven M Opal
Critical Care Clinics|March 29, 2011
Biomarkers: the futureSteven P LaRosa, Steven M Opal
Critical Care (London, England)|November 6, 2009
Year in review 2008: Critical Care--sepsisSteven M Opal, Steven P LaRosa
Critical Care (London, England)|May 2, 2002
Bench-to-bedside review: Toll-like receptors and their role in septic shockSteven M Opal, Christian E Huber
Shock (Augusta, Ga.)|December 24, 2005
The use of immunocompromised animals as models for human septic shockSteven M Opal, Alan S Cross
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Current Infectious Disease Reports|August 2, 2012
Immune aspects of sepsis and hope for new therapeuticsSteven P Larosa, Steven M Opal
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Novel approaches to the treatment of systemic anthraxAndrew W Artenstein, Steven M Opal
Current Infectious Disease Reports|May 6, 2015
Sepsis in the severely immunocompromised patientAndre C Kalil, Steven M Opal
Critical Care Clinics|July 5, 2005
Tissue factor pathway inhibitor and antithrombin trial resultsSteven P LaRosa, Steven M Opal
Critical Care Medicine|November 27, 2013
The authors replySteven M Opal, R Phillip Dellinger
Virulence|November 9, 2013
The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shockAurora Pop-Vicas, Steven M Opal
Critical Care Clinics|March 29, 2011
Biomarkers: the futureSteven P LaRosa, Steven M Opal
Critical Care (London, England)|November 6, 2009
Year in review 2008: Critical Care--sepsisSteven M Opal, Steven P LaRosa
Critical Care (London, England)|May 2, 2002
Bench-to-bedside review: Toll-like receptors and their role in septic shockSteven M Opal, Christian E Huber
Shock (Augusta, Ga.)|December 24, 2005
The use of immunocompromised animals as models for human septic shockSteven M Opal, Alan S Cross
Pageof 17